NEURANA PHARMACEUTICALS
Neurana Pharmaceuticals is a biotechnology company that is currently developing a novel treatment for acute muscle spasms. The company was founded in 2013 and headquartered in California, United States.
NEURANA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.neuranapharma.com
Total Employee:
1+
Status:
Active
Contact:
+1 858-732-0700
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Microsoft Exchange Online Google GStatic Google Static Content Google Cloud
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Current Advisors List
Josh Richardson Board Of Director @ Neurana Pharmaceuticals Board_member 2018-05-01
Alex Zisson Board Of Director @ Neurana Pharmaceuticals Board_member
David Kabakoff Board Of Director @ Neurana Pharmaceuticals Board_member
Dan Becker Board Of Director @ Neurana Pharmaceuticals Board_member
Current Employees Featured
Kathy Scott
Kathy Scott Senior Vice President & CFO @ Neurana Pharmaceuticals Senior Vice President & CFO 2016-01-01
David Hale
David Hale Chairman, President & CEO @ Neurana Pharmaceuticals Chairman, President & CEO
Judy Caron
Judy Caron COO & Head of Clinical Development @ Neurana Pharmaceuticals COO & Head of Clinical Development
Craig Thompson
Craig Thompson President and CEO @ Neurana Pharmaceuticals President and CEO 2018-07-01
Randall Kaye
Randall Kaye CMO @ Neurana Pharmaceuticals CMO 2019-10-01
Founder
David Hale
Judy Caron
Investors List
MagnaSci Ventures
MagnaSci Ventures investment in Series A - Neurana Pharmaceuticals
Longitude Capital
Longitude Capital investment in Series A - Neurana Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series A - Neurana Pharmaceuticals
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series A - Neurana Pharmaceuticals
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - Neurana Pharmaceuticals
Official Site Inspections
http://www.neuranapharma.com
- Host name: 199.59.243.225
- IP address: 199.59.243.225
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Loading ...